Lilly, Amylin, Merck Diabetes Drug Ri...

Lilly, Amylin, Merck Diabetes Drug Risks Highlighted

There are 1 comment on the Minyanville story from Sep 14, 2011, titled Lilly, Amylin, Merck Diabetes Drug Risks Highlighted. In it, Minyanville reports that:

Hope for the diabetes drug Bydureon -- developed by Amylin Pharmaceuticals , Eli Lilly , and Alkermes -- has ebbed and flowed over the past year.

Join the discussion below, or Read more at Minyanville.


Winnipeg, Canada

#1 Sep 14, 2011
Pharma CEO's should be in prison.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Eli Lilly Discussions

Title Updated Last By Comments
News Veritas Genetics draws $30 million in funding (Oct '16) Oct '16 Stephany McDowell 1
News Icos to announce shareholder vote on Lilly bid (Jan '07) Jan '16 Evenstad 14
News Lilly to acquire Icos for $2 billion (Oct '06) Jan '16 Juan 30
News Lilly accused of price-fixing in Switzerland (Feb '09) Jan '16 Ellerby 17
News Icos leaders to get $68 million from company's ... (Nov '06) Jan '16 Madlem 20
News Eli Lilly: Experimental Alzheimer's drug shows ... (Jul '15) Jul '15 humanspirit 1
News Vivus Drug Helps Men Get Erections in 30 Minute... (Nov '09) Jun '15 Empty 16